Posted by ABMN Staff on May 3rd, 2024
10x Genomics (NASDAQ:TXG – Get Free Report) had its target price reduced by investment analysts at Bank of America from $45.00 to $36.00 in a report issued on Wednesday, Benzinga reports. The firm currently has a “neutral”...
More of this article »